Press-release for stocks related to therapeutics

Prices are updated after-hours

tags : Therapeutics crawled date : 2022 - 02 - 28

save search

Design Therapeutics Announces FDA Clearance of Investigational New Drug Application for First GeneTAC™ Molecule for Friedreich Ataxia
Published: 2022-02-28 (Crawled : 23:00) - biospace.com/
DSGN | $3.645 -6.3% -6.72% 160K

Professional, Scientific, and T...

| -71.25% | O: -1.4% H: 3.68% C: 1.72%
new drug fda clearance application drug therapeutics fda clearance friedreich's ataxia designation friedreich’s ataxia

Nektar Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results
Published: 2022-02-28 (Crawled : 23:00) - biospace.com/
NKTR | News | $1.415 4.04% 3.89% 1.1M

Health Technology

| -86.37% | O: -1.1% H: 4.15% C: 3.75%
financial results therapeutics report results

Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2021 and Highlights Recent Corporate Updates
Published: 2022-02-28 (Crawled : 23:00) - biospace.com/
HRTX M | $2.805 8.3% 7.66% 6.6M

Health Technology

| -65.7% | O: -1.72% H: 1.89% C: -4.31%
financial results ces therapeutics results

Atossa Therapeutics Announces Year-End 2021 Financial Results and Provides Corporate Update
Published: 2022-02-28 (Crawled : 22:00) - atossatherapeutics.com
ATOS | $1.485 4.58% 4.38% 1.1M

Health Technology

| 13.6% | O: -1.6% H: 2.44% C: -0.81%
financial results ces therapeutics results

Arcturus Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Update and Pipeline Progress
Published: 2022-02-28 (Crawled : 22:00) - biospace.com/
TAK | News | $13.38 0.15% 0.9% 1.7M

Health Technology

| -10.64% | O: 0.54% H: 1.66% C: 1.13%
JNJ | News | $149.56 0.3% 0.0% 9.1M

Health Technology

| -6.78% | O: 1.79% H: 0.0% C: 0.0%
ARCT 4 | $27.93 3.22% 3.11% 310K

Health Technology

| 14.47% | O: -0.93% H: 3.16% C: 2.35%
ces therapeutics

Atara Biotherapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Operational Progress
Published: 2022-02-28 (Crawled : 22:00) - biospace.com/
ATRA | $0.7199 3.23% 3.13% 830K

Health Technology

| -94.69% | O: -0.61% H: 1.41% C: -1.98%
financial results ces therapeutics results iot

CytomX Therapeutics to Present at Cowen 42nd Annual Healthcare Conference
Published: 2022-02-28 (Crawled : 20:00) - biospace.com/
CTMX | $1.68 0.6% 0.6% 290K

Health Technology

| -58.56% | O: -0.25% H: 0.37% C: -4.73%
health thc conference therapeutics

Pliant Therapeutics Announces Positive Data from Expanded Phase 1b BAL Trial of PLN-74809 Demonstrated Suppression of TGF-β Signaling in Healthy Volunteers
Published: 2022-02-28 (Crawled : 15:30) - biospace.com/
PLRX | $12.505 -0.75% -0.76% 240K

Health Technology

| 30.57% | O: -0.41% H: 0.0% C: 0.0%
pln-7480 health phase 1b trial therapeutics phase 1 positive phase 2b

Travere Therapeutics Recognizes Rare Disease Day 2022 and Raises Awareness for People Living with Rare Disease
Published: 2022-02-28 (Crawled : 15:00) - travere.com
TVTX | $5.745 -1.8% -1.83% 1.2M

Health Technology

| -78.21% | O: 1.08% H: 3.98% C: 0.44%
day rare therapeutics disease

Virios Therapeutics Announces Research Collaboration Exploring the Potential of Combination Antiviral Therapy for Treating Long COVID
Published: 2022-02-28 (Crawled : 15:00) - biospace.com/
VIRI | $0.4218 -0.92% -0.92% 60K

Health Technology

| -92.52% | O: 0.52% H: 1.56% C: -2.08%
research therapeutics covid potential therapy collaboration antiviral

Blueprint Medicines and Proteovant Therapeutics Announce Strategic Collaboration to Advance Novel Targeted Protein Degrader Therapies
Published: 2022-02-28 (Crawled : 15:00) - biospace.com/
BPMC | $92.32 1.89% 1.85% 790K

Health Technology

| 45.72% | O: -0.53% H: 0.95% C: -2.1%
therapeutics blue collaboration therapy

Jounce Therapeutics to Participate in Cowen & Co. 42nd Annual Health Care Conference
Published: 2022-02-28 (Crawled : 14:30) - biospace.com/
JNCE | $1.88 -2.59% -1.85% 0

Health Technology

| -73.8% | O: -0.96% H: 4.46% C: 3.32%
GILD | $67.03 0.12% 0.12% 5.2M

Health Technology

| 10.01% | O: -1.0% H: 0.37% C: 0.25%
health conference therapeutics

NeuBase Therapeutics to Present New Preclinical Data for Myotonic Dystrophy Type 1 Program at the 2022 MDA Clinical & Scientific Conference
Published: 2022-02-28 (Crawled : 14:30) - biospace.com/
NBSE | $0.4399 4.74% 4.52% 58K

Health Technology

| -70.42% | O: 2.11% H: 9.62% C: 2.07%
program conference therapeutics preclinical pre-clinical

Akari Therapeutics Announces New Data Showing A Significant Role for Complement Activation in the Clinical Outcomes of U.S. Army Trauma Patients in Iraq and the Therapeutic Potential of Nomacopan for Treatment of Trauma
Published: 2022-02-28 (Crawled : 14:30) - globenewswire.com
AKTX | $1.22 3.39% 3.28% 4.8K

Health Technology

| -9.23% | O: 3.85% H: 1.55% C: 0.0%
treatment therapeutics potential

Seelos Therapeutics Announces Dosing of the First Participants in a Registrational Phase II/III Trial of SLS-005 in Amyotrophic Lateral Sclerosis on the HEALEY ALS Platform
Published: 2022-02-28 (Crawled : 14:00) - biospace.com/
SEEL | $0.326 0.09% 0.09% 380K

Health Technology

| -68.87% | O: -0.94% H: 5.71% C: 0.95%
sls-005 als trial therapeutics sclerosis platform

Lyra Therapeutics Announces First Patient Dosed in Pivotal ENLIGHTEN I Clinical Trial of LYR-210 in Chronic Rhinosinusitis Patients
Published: 2022-02-28 (Crawled : 13:30) - biospace.com/
LYRA | $5.22 0.19% 0.19% 230K

Health Technology

| 1.17% | O: -1.94% H: 5.94% C: -3.56%
lyr-210 ces trial therapeutics

The Australian Natural Therapeutics Group Signs a US$7.8M Product Agreement With Clever Leaves to Accelerate Medical Cannabis Access in Australia
Published: 2022-02-28 (Crawled : 13:00) - ir.cleverleaves.com
CLVR | $3.76 -1.96% -1.99% 4.1K

| 221.85% | O: 0.84% H: 5.0% C: -2.5%
ces cannabis therapeutics cel australia group

Applied Therapeutics Supports 15th Annual Rare Disease Day
Published: 2022-02-28 (Crawled : 13:00) - appliedtherapeutics.com
APLT | $4.455 1.02% 1.01% 400K

Health Technology